Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2

Comparison 9.

Vaginal isosorbide mononitrate (IMN) versus placebo

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Vaginal delivery not achieved in 24/48 hrs 1 238 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.83, 1.15]
2 Additional induction agents required 3 559 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.74, 0.92]
3 Serious maternal morbidity or death 0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4 Maternal satisfaction (women would recommend procedure) 1 193 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.94, 1.08]
5 Maternal satisfaction (various questions, low score= satisfied, high score = dissatisfied, score out of 10) 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
 5.1 How do you think your labour went? (easy/very difficult) 1 227 Mean Difference (IV, Fixed, 95% CI) −0.34 [−0.94, 0.26]
 5.2 What do you think about home treatment? (extremely good/not at all good) 1 227 Mean Difference (IV, Fixed, 95% CI) 0.61 [0.03, 1.19]
 5.3 How painful was the treatment at home? (not at all/very) 1 227 Mean Difference (IV, Fixed, 95% CI) 0.58 [−0.00, 1.16]
 5.4 How anxious were you being at home taking the treatment? (not at all/very) 1 227 Mean Difference (IV, Fixed, 95% CI) 0.11 [−0.39, 0.61]
 5.5 Would you have the same treatment at home again? (definitely/definitely not) 1 227 Mean Difference (IV, Fixed, 95% CI) 0.62 [−0.02, 1.26]
 5.6 Would you advise a friend to have the same treatment at home? (definitely/definitely not) 1 227 Mean Difference (IV, Fixed, 95% CI) 0.41 [−0.17, 0.99]
6 Postpartum haemorrhage (> 500 ml) 3 256 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [0.89, 1.59]
7 Caesarean section 3 652 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.81, 1.31]
8 Assisted (instrumental) vaginal delivery 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.61, 1.18]
9 Oxytocin augmentation 1 254 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.88, 1.30]
10 Epidural 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.82, 1.09]
11 Cervix unchanged after 48 hrs 1 257 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.70, 0.97]
12 Maternal side effect - headache 3 522 Risk Ratio (M-H, Fixed, 95% CI) 5.41 [3.85, 7.60]
13 Maternal side effect - nausea 2 420 Risk Ratio (M-H, Fixed, 95% CI) 2.06 [1.22, 3.50]
14 Admitted in established labour within 24 hours 1 200 Risk Ratio (M-H, Fixed, 95% CI) 2.75 [1.29, 5.88]
15 Uterine hyperstimulation (with FHR changes) 1 102 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 4.07]
16 Side effects: severe headache 1 220 Risk Ratio (M-H, Fixed, 95% CI) 21.21 [2.91, 154.65]
17 Total cost of care package (GB £) 1 350 Mean Difference (IV, Fixed, 95% CI) 11.98 [−105.34, 129.30]
18 Perinatal death 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.94]
19 Apgar score < 7 at 5 minutes 3 3 256 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.35, 4.17]
20 NICU admission 3 652 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.72, 1.92]
21 Interval from admission to vaginal delivery (hours) 1 128 Mean Difference (IV, Fixed, 95% CI) −0.70 [−6.11, 4.71]
22 Neonatal infection 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.26, 3.89]
23 Bishop score > 6 or active labour at 36 hours 1 102 Risk Ratio (M-H, Fixed, 95% CI) 3.8 [1.54, 9.40]
24 Time in hours from admission to delivery (all women) 1 102 Mean Difference (IV, Fixed, 95% CI) −6.67 [−9.56, −3.78]
25 Onset of labour within 24 hours 1 200 Risk Ratio (M-H, Fixed, 95% CI) 2.75 [1.29, 5.88]